Loading…
Three year surveillance study of nosocomial bacterial resistance in Argentina
Introduction: A national surveillance program (SIR) was introduced in 1996 in Argentina by the Antimicrobial Committee of the Argentinean Society for Microbiology to assess bacterial resistance. The present study reports the rates of nosocomial bacterial resistance found by this program. Methods: A...
Saved in:
| Published in: | International journal of infectious diseases 2000, Vol.4 (2), p.85-90 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393 |
| container_end_page | 90 |
| container_issue | 2 |
| container_start_page | 85 |
| container_title | International journal of infectious diseases |
| container_volume | 4 |
| creator | Bantar, Carlos Famiglietti, Angela Goldberg, Mirta The Antimicrobial Committee |
| description | Introduction: A national surveillance program (SIR) was introduced in 1996 in Argentina by the Antimicrobial Committee of the Argentinean Society for Microbiology to assess bacterial resistance. The present study reports the rates of nosocomial bacterial resistance found by this program.
Methods: A 2-month point-prevalence study was conducted twice yearly (i.e., April-May and October-November) from 1996 to 1998, by 27 Argentinean centers. Susceptibility testing was carried out by the disk diffusion method following the National Committee for Clinical Laboratory Standards guidelines.
Results: In all, 6343 isolates recovered from 5603 inpatients (≥48-hr hospitalization) were included. Methicillin resistance was 58% and 56% in
Staphylococcus aureus and coagulase-negative staphylococci (CNS), respectively. Although no vancomycin resistance was found in staphylococci, 2% and 8% of the
S. aureus and CNS strains, respectively, proved resistant to teicoplanin. No ampicillin resistance was displayed by
Enterococcus faecalis. High-level gentamicin and streptomycin resistance in enterococci were 33% and 37%, respectively. Acquired glycopeptide resistance in enterococci emerged in 1997 (2%). Imipenem resistance in
Acinetobacter spp and
Pseudomonas aeruginosa was 9% and 21%, respectively. Among
Enterobacteriaceae, 1 % and 5% of the
Klebsiella pneumoniae and
Enterobacter cloacae isolates, respectively, proved resistant to imipenem. Ceftazidime and cefepime resistance was found in 63% and 33% of the
E. cloacae strains. Resistance to extended-spectrum cephalosporins was shown by 48%, 26%, and 8% of the
K. pneumoniae, Proteus mirabilis, and
Escherichia coli isolates, respectively.
Conclusions: The alarming rates of resistance found in this study provide compelling evidence of the need for more rational use of antimicrobial agents in Argentina. |
| doi_str_mv | 10.1016/S1201-9712(00)90099-7 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_229501217</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1201971200900997</els_id><sourcerecordid>51658085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMoWKs_QVjEgx5WJ8lud3OSUvyCigfrOWSTWU3ZbmqyW-i_N9sqHj3NwDwzw_sQck7hhgKd3L5RBjQVBWVXANcCQIi0OCAjWhZlynNKD2P_ixyTkxCWAJBNJuWIvCw-PWKyReWT0PsN2qZRrcYkdL3ZJq5OWhecdiurmqRSukM_dB6DDd0OtG0y9R_YdrZVp-SoVk3As586Ju8P94vZUzp_fXyeTeep5iwvUm5KjcCoyozgUEFuSiXiAIqc84plrKirOkNeMlYbjbQSFWNmYgrOwVRc8DG52N9de_fVY-jk0vW-jS8lYyIHymgRoXwPae9C8FjLtbcr5beSghzEyZ04OViRAHInTg57lz_HVdCqqX2MacPfMs9FxmjE7vYYxqAbi14GbTEaMdaj7qRx9p9H36T6gVk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229501217</pqid></control><display><type>article</type><title>Three year surveillance study of nosocomial bacterial resistance in Argentina</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Bantar, Carlos ; Famiglietti, Angela ; Goldberg, Mirta ; The Antimicrobial Committee</creator><creatorcontrib>Bantar, Carlos ; Famiglietti, Angela ; Goldberg, Mirta ; The Antimicrobial Committee ; National Surveillance Program (SIR) Participants Group</creatorcontrib><description>Introduction: A national surveillance program (SIR) was introduced in 1996 in Argentina by the Antimicrobial Committee of the Argentinean Society for Microbiology to assess bacterial resistance. The present study reports the rates of nosocomial bacterial resistance found by this program.
Methods: A 2-month point-prevalence study was conducted twice yearly (i.e., April-May and October-November) from 1996 to 1998, by 27 Argentinean centers. Susceptibility testing was carried out by the disk diffusion method following the National Committee for Clinical Laboratory Standards guidelines.
Results: In all, 6343 isolates recovered from 5603 inpatients (≥48-hr hospitalization) were included. Methicillin resistance was 58% and 56% in
Staphylococcus aureus and coagulase-negative staphylococci (CNS), respectively. Although no vancomycin resistance was found in staphylococci, 2% and 8% of the
S. aureus and CNS strains, respectively, proved resistant to teicoplanin. No ampicillin resistance was displayed by
Enterococcus faecalis. High-level gentamicin and streptomycin resistance in enterococci were 33% and 37%, respectively. Acquired glycopeptide resistance in enterococci emerged in 1997 (2%). Imipenem resistance in
Acinetobacter spp and
Pseudomonas aeruginosa was 9% and 21%, respectively. Among
Enterobacteriaceae, 1 % and 5% of the
Klebsiella pneumoniae and
Enterobacter cloacae isolates, respectively, proved resistant to imipenem. Ceftazidime and cefepime resistance was found in 63% and 33% of the
E. cloacae strains. Resistance to extended-spectrum cephalosporins was shown by 48%, 26%, and 8% of the
K. pneumoniae, Proteus mirabilis, and
Escherichia coli isolates, respectively.
Conclusions: The alarming rates of resistance found in this study provide compelling evidence of the need for more rational use of antimicrobial agents in Argentina.</description><identifier>ISSN: 1201-9712</identifier><identifier>EISSN: 1878-3511</identifier><identifier>DOI: 10.1016/S1201-9712(00)90099-7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Biological and medical sciences ; Epidemiology. Vaccinations ; General aspects ; Infectious diseases ; Medical sciences ; nosocomial infections ; resistance ; surveillance ; Tropical medicine</subject><ispartof>International journal of infectious diseases, 2000, Vol.4 (2), p.85-90</ispartof><rights>2000</rights><rights>2000 INIST-CNRS</rights><rights>Copyright Decker Periodicals, Inc. 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393</citedby><cites>FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,4043,27956,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1359421$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Bantar, Carlos</creatorcontrib><creatorcontrib>Famiglietti, Angela</creatorcontrib><creatorcontrib>Goldberg, Mirta</creatorcontrib><creatorcontrib>The Antimicrobial Committee</creatorcontrib><creatorcontrib>National Surveillance Program (SIR) Participants Group</creatorcontrib><title>Three year surveillance study of nosocomial bacterial resistance in Argentina</title><title>International journal of infectious diseases</title><description>Introduction: A national surveillance program (SIR) was introduced in 1996 in Argentina by the Antimicrobial Committee of the Argentinean Society for Microbiology to assess bacterial resistance. The present study reports the rates of nosocomial bacterial resistance found by this program.
Methods: A 2-month point-prevalence study was conducted twice yearly (i.e., April-May and October-November) from 1996 to 1998, by 27 Argentinean centers. Susceptibility testing was carried out by the disk diffusion method following the National Committee for Clinical Laboratory Standards guidelines.
Results: In all, 6343 isolates recovered from 5603 inpatients (≥48-hr hospitalization) were included. Methicillin resistance was 58% and 56% in
Staphylococcus aureus and coagulase-negative staphylococci (CNS), respectively. Although no vancomycin resistance was found in staphylococci, 2% and 8% of the
S. aureus and CNS strains, respectively, proved resistant to teicoplanin. No ampicillin resistance was displayed by
Enterococcus faecalis. High-level gentamicin and streptomycin resistance in enterococci were 33% and 37%, respectively. Acquired glycopeptide resistance in enterococci emerged in 1997 (2%). Imipenem resistance in
Acinetobacter spp and
Pseudomonas aeruginosa was 9% and 21%, respectively. Among
Enterobacteriaceae, 1 % and 5% of the
Klebsiella pneumoniae and
Enterobacter cloacae isolates, respectively, proved resistant to imipenem. Ceftazidime and cefepime resistance was found in 63% and 33% of the
E. cloacae strains. Resistance to extended-spectrum cephalosporins was shown by 48%, 26%, and 8% of the
K. pneumoniae, Proteus mirabilis, and
Escherichia coli isolates, respectively.
Conclusions: The alarming rates of resistance found in this study provide compelling evidence of the need for more rational use of antimicrobial agents in Argentina.</description><subject>Biological and medical sciences</subject><subject>Epidemiology. Vaccinations</subject><subject>General aspects</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>nosocomial infections</subject><subject>resistance</subject><subject>surveillance</subject><subject>Tropical medicine</subject><issn>1201-9712</issn><issn>1878-3511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LAzEQhoMoWKs_QVjEgx5WJ8lud3OSUvyCigfrOWSTWU3ZbmqyW-i_N9sqHj3NwDwzw_sQck7hhgKd3L5RBjQVBWVXANcCQIi0OCAjWhZlynNKD2P_ixyTkxCWAJBNJuWIvCw-PWKyReWT0PsN2qZRrcYkdL3ZJq5OWhecdiurmqRSukM_dB6DDd0OtG0y9R_YdrZVp-SoVk3As586Ju8P94vZUzp_fXyeTeep5iwvUm5KjcCoyozgUEFuSiXiAIqc84plrKirOkNeMlYbjbQSFWNmYgrOwVRc8DG52N9de_fVY-jk0vW-jS8lYyIHymgRoXwPae9C8FjLtbcr5beSghzEyZ04OViRAHInTg57lz_HVdCqqX2MacPfMs9FxmjE7vYYxqAbi14GbTEaMdaj7qRx9p9H36T6gVk</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Bantar, Carlos</creator><creator>Famiglietti, Angela</creator><creator>Goldberg, Mirta</creator><creator>The Antimicrobial Committee</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Decker Periodicals, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FQ</scope><scope>8FV</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M3G</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>2000</creationdate><title>Three year surveillance study of nosocomial bacterial resistance in Argentina</title><author>Bantar, Carlos ; Famiglietti, Angela ; Goldberg, Mirta ; The Antimicrobial Committee</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Biological and medical sciences</topic><topic>Epidemiology. Vaccinations</topic><topic>General aspects</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>nosocomial infections</topic><topic>resistance</topic><topic>surveillance</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bantar, Carlos</creatorcontrib><creatorcontrib>Famiglietti, Angela</creatorcontrib><creatorcontrib>Goldberg, Mirta</creatorcontrib><creatorcontrib>The Antimicrobial Committee</creatorcontrib><creatorcontrib>National Surveillance Program (SIR) Participants Group</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Canadian Business & Current Affairs Database</collection><collection>Canadian Business & Current Affairs Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>CBCA Reference & Current Events</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>International journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bantar, Carlos</au><au>Famiglietti, Angela</au><au>Goldberg, Mirta</au><au>The Antimicrobial Committee</au><aucorp>National Surveillance Program (SIR) Participants Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Three year surveillance study of nosocomial bacterial resistance in Argentina</atitle><jtitle>International journal of infectious diseases</jtitle><date>2000</date><risdate>2000</risdate><volume>4</volume><issue>2</issue><spage>85</spage><epage>90</epage><pages>85-90</pages><issn>1201-9712</issn><eissn>1878-3511</eissn><abstract>Introduction: A national surveillance program (SIR) was introduced in 1996 in Argentina by the Antimicrobial Committee of the Argentinean Society for Microbiology to assess bacterial resistance. The present study reports the rates of nosocomial bacterial resistance found by this program.
Methods: A 2-month point-prevalence study was conducted twice yearly (i.e., April-May and October-November) from 1996 to 1998, by 27 Argentinean centers. Susceptibility testing was carried out by the disk diffusion method following the National Committee for Clinical Laboratory Standards guidelines.
Results: In all, 6343 isolates recovered from 5603 inpatients (≥48-hr hospitalization) were included. Methicillin resistance was 58% and 56% in
Staphylococcus aureus and coagulase-negative staphylococci (CNS), respectively. Although no vancomycin resistance was found in staphylococci, 2% and 8% of the
S. aureus and CNS strains, respectively, proved resistant to teicoplanin. No ampicillin resistance was displayed by
Enterococcus faecalis. High-level gentamicin and streptomycin resistance in enterococci were 33% and 37%, respectively. Acquired glycopeptide resistance in enterococci emerged in 1997 (2%). Imipenem resistance in
Acinetobacter spp and
Pseudomonas aeruginosa was 9% and 21%, respectively. Among
Enterobacteriaceae, 1 % and 5% of the
Klebsiella pneumoniae and
Enterobacter cloacae isolates, respectively, proved resistant to imipenem. Ceftazidime and cefepime resistance was found in 63% and 33% of the
E. cloacae strains. Resistance to extended-spectrum cephalosporins was shown by 48%, 26%, and 8% of the
K. pneumoniae, Proteus mirabilis, and
Escherichia coli isolates, respectively.
Conclusions: The alarming rates of resistance found in this study provide compelling evidence of the need for more rational use of antimicrobial agents in Argentina.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><doi>10.1016/S1201-9712(00)90099-7</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1201-9712 |
| ispartof | International journal of infectious diseases, 2000, Vol.4 (2), p.85-90 |
| issn | 1201-9712 1878-3511 |
| language | eng |
| recordid | cdi_proquest_journals_229501217 |
| source | BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS |
| subjects | Biological and medical sciences Epidemiology. Vaccinations General aspects Infectious diseases Medical sciences nosocomial infections resistance surveillance Tropical medicine |
| title | Three year surveillance study of nosocomial bacterial resistance in Argentina |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T14%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Three%20year%20surveillance%20study%20of%20nosocomial%20bacterial%20resistance%20in%20Argentina&rft.jtitle=International%20journal%20of%20infectious%20diseases&rft.au=Bantar,%20Carlos&rft.aucorp=National%20Surveillance%20Program%20(SIR)%20Participants%20Group&rft.date=2000&rft.volume=4&rft.issue=2&rft.spage=85&rft.epage=90&rft.pages=85-90&rft.issn=1201-9712&rft.eissn=1878-3511&rft_id=info:doi/10.1016/S1201-9712(00)90099-7&rft_dat=%3Cproquest_cross%3E51658085%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3257-3d8ce021a4d930b05d8a925707533b2427fbf4e3822fdce1b9b22d6d7330db393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=229501217&rft_id=info:pmid/&rfr_iscdi=true |